The modulation of RPE glycolysis through VHL manipulation in rod photoreceptors represents another promising preclinical approach that has demonstrated efficacy in improving disease phenotypes in experimental RP models [39]. This evidence concerns the gene VHL and retinitis pigmentosa 1.